[ad_1]
This is the first time that citizens outside of global clinical trials will have the opportunity to be vaccinated against Covid-19, according to BioNTech CEO Ugur Sahin.
The vaccine will be available across the UK from next week, a spokesperson for the Department of Health and Social Affairs said in a statement. More details will be released soon, including advice for priority groups like the elderly and healthcare workers to receive the vaccine.
“To contribute to the success of the vaccination program, it is essential that everyone continues to play their part and adhere to the necessary restrictions in their region so that we can further suppress the virus and allow the NHS to do its job without being overwhelmed”, said the spokesperson. .
“The vaccine will be available across the UK from next week. The NHS has decades of experience in implementing large-scale vaccination programs and will begin to implement its extensive preparations to provide care and support for all those eligible for vaccination, ”the statement said. added.
In a press release, Pfizer CEO Albert Bourla hailed the emergency clearance as “a historic moment in the fight against Covid-19”.
“This clearance is a goal we have been working towards since we first declared that science would win, and we commend (the Medicines and Health Products Regulatory Agency) for its ability to conduct a careful assessment and to take timely action to help protect the people of the UK, ”he said.
Sahin added that the regulatory data was the result of a “scientifically rigorous and highly ethical research and development program.”
The companies had previously signed an agreement to supply 40 million doses to the UK with delivery in 2020 and 2021.
Other countries, including the United States, are considering approving various coronavirus vaccines before the end of the year.
[ad_2]
Source link